This non-promotional symposium was organised and funded by AstraZeneca.
There is an urgent need to elevate the importance of good lung health among patients, healthcare professionals, the general public, policy makers, and regulatory bodies to facilitate proactive management of lung health. This symposium brought together a panel of global experts to explore strategies to achieve better lung health for patients with respiratory disease through individualised care, shifting mindsets, and raising the profile of lung health throughout society.
Topics covered:
- What does good lung health mean to patients living with respiratory disease?
- How can we intervene to improve lung health and prevent disease?
- How can we ensure that good lung health is prioritised by society?
Speakers
Rosa Faner1
Andrew Menzies-Gow2
James Allinson3
Christine Jenkins4
1. University of Barcelona, Spain
2. Global Medical Head, AstraZeneca, UK
3. Imperial College London via Imperial College London Consultants, UK
4. University of New South Wales, Sydney, Australia
